DBpedia – Linked Data Fragments

Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd> ?p ?o }

• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd abstract "Kirin-Amgen, Inc. v Hoechst Marion Roussel Ltd. is a decision by the House of Lords of England and Wales. The judgment was issued on 21 October 2004 and relates to the scope to be accorded to patent claims, including the doctrine of equivalents. The case and subsequent judgment affirmed principles from a prior case, Catnic Components Ltd. v. Hill & Smith Ltd. The issue was whether the claims of a European patent granted to Kirin-Amgen, Inc. were infringed by Transkaryotic Therapies Inc. and Hoechst Marion Roussel Ltd in a situation where there was a remarkable similarity between the technologies employed by the two parties for producing the hormone erythropoietin. Infringement was not found due to the language used in the claims of the Amgen patent. The reasoning in the judgment has presently formed a basis for the current practice of the UK Intellectual Property Office, and other countries that take great consideration of the legal implications of British case law, when assessing whether a patent has been infringed by a device or process which is equivalent to the patented invention. (See also Doctrine of equivalents.)".
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageID "14351738".
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageLength "18113".
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageOutDegree "56".
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageRevisionID "673048240".
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Alan_Rodger,_Baron_Rodger_of_Earlsferry.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Amino_acid.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Bone_marrow.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Category:2004_in_British_law.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Category:2004_in_case_law.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Category:House_of_Lords_cases.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Category:United_Kingdom_patent_case_law.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Catnic_Components_Ltd._v._Hill_&_Smith_Ltd..
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Catnic_Components_Ltd_v_Hill_&_Smith_Ltd.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Cell_division.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink DNA_sequence.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink David_Hope,_Baron_Hope_of_Craighead.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Doctrine_of_equivalents.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Erythropoietin.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Eukaryote.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink European_Patent_Convention.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Exogenous_DNA.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Gene.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Gene_activation.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Glycoprotein.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Haemoglobin.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Hemoglobin.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Hoechst_AG.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Hoechst_Marion_Roussel.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink House_of_Lords.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Improver_Corp_v_Remington_Consumer_Product_Ltd.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Improver_v._Remington.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Improver_v_Remington.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Kenneth_Diplock,_Baron_Diplock.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Kidney.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Kirin-Amgen.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Kirin-Amgen,_Inc..
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Leonard_Hoffmann,_Baron_Hoffmann.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Lord_Brown_of_Eaton-under-Heywood.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Lord_Diplock.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Lord_Hoffmann.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Lord_Hope_of_Craighead.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Lord_Rodger_of_Earlsferry.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Lord_Walker_of_Gestingthorpe.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Lord_of_Appeal_in_Ordinary.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Lords_of_Appeal_in_Ordinary.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Messenger_RNA.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Metaphor.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Metonymy.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Microbiological_culture.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Nucleic_acid_sequence.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Patent_infringement.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Peptide.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Pharmaceutical_company.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Pharmaceutical_industry.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Polyacrylamide_gel_electrophoresis.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Prokaryote.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Promoter_(biology).
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Promoter_(genetics).
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Recombinant_DNA.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Red_blood_cell.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Red_blood_cells.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Regulation_of_gene_expression.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Reticulocyte.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Robert_Walker,_Baron_Walker_of_Gestingthorpe.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink SDS-PAGE.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Samuel_Porter,_Baron_Porter.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Shire_(pharmaceutical_company).
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Shire_plc.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Simile.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Simon_Brown,_Baron_Brown_of_Eaton-under-Heywood.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Synecdoche.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Transcription_(genetics).
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLink Transfection.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageWikiLinkText "Kirin-Amgen Inc v Hoechst Marion Roussel Ltd".
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd hasPhotoCollection Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageUsesTemplate Template:Cite_patent.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageUsesTemplate Template:Cquote.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wikiPageUsesTemplate Template:Reflist.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd subject Category:2004_in_British_law.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd subject Category:2004_in_case_law.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd subject Category:House_of_Lords_cases.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd subject Category:United_Kingdom_patent_case_law.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd comment "Kirin-Amgen, Inc. v Hoechst Marion Roussel Ltd. is a decision by the House of Lords of England and Wales. The judgment was issued on 21 October 2004 and relates to the scope to be accorded to patent claims, including the doctrine of equivalents. The case and subsequent judgment affirmed principles from a prior case, Catnic Components Ltd. v. Hill & Smith Ltd. The issue was whether the claims of a European patent granted to Kirin-Amgen, Inc. were infringed by Transkaryotic Therapies Inc.".
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd label "Kirin-Amgen Inc v Hoechst Marion Roussel Ltd".
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd sameAs m.03d1cdr.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd sameAs Q6415303.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd sameAs Q6415303.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd wasDerivedFrom Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd?oldid=673048240.
• Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd isPrimaryTopicOf Kirin-Amgen_Inc_v_Hoechst_Marion_Roussel_Ltd.